Li Huo
Impact in
- Oncology top 2%
- Peptidase Inhibition and Analysis
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Papers in
- Oncology 73
- Peptidase Inhibition and Analysis 37
-
- Medical Imaging Techniques and Applications 28
- Radiomics and Machine Learning in Medical Imaging 21
- Radiopharmaceutical Chemistry and Applications 15
Li Huo
192 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 1.3k
- Radiology, Nuclear Medicine and Imaging 741
- Nephrology 228
- Cancer Research 479
- Surgery 757
Countries citing papers authored by Li Huo
This map shows the geographic impact of Li Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Huo more than expected).
Fields of papers citing papers by Li Huo
This network shows the impact of papers produced by Li Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Huo. The network helps show where Li Huo may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Huo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 11 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 20 | |
| 10 | 2023 | 26 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 24 | |
| 13 | 2021 | 19 | |
| 14 | 2021 | 18 | |
| 15 | 2020 | 111 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 59 | |
| 18 | 2019 | 80 | |
| 19 | 2019 | 4 | |
| 20 | Some Remarks on (F_1,F_2)-Scrambled Sets | 2010 | 2 |
About Li Huo
Li Huo is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Nephrology, Aquatic Science and Cancer Research, having authored 209 papers that have together received 2.7k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (37 papers), Medical Imaging Techniques and Applications (28 papers), Neuroendocrine Tumor Research Advances (24 papers), Medical Imaging and Pathology Studies (23 papers), Radiomics and Machine Learning in Medical Imaging (21 papers), Adrenal and Paraganglionic Tumors (18 papers), Radiopharmaceutical Chemistry and Applications (15 papers) and Parathyroid Disorders and Treatments (15 papers). The work is most often cited by research in Oncology (1.3k citations), Radiology, Nuclear Medicine and Imaging (741 citations), Nephrology (228 citations), Cancer Research (479 citations) and Surgery (757 citations). Li Huo has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Jie Ding, Haiqun Xing, Xiang Li, Wenjia Zhu, Shaobo Yao, Marcus Hacker, Ximin Shi, Mengxin Xu, Junyi Chen and Haitao Zhao. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, EJNMMI Physics, Journal of Nuclear Cardiology and Clinical Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.